These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21366258)

  • 1. Magnesium chelating 2-hydroxyisoquinoline-1,3(2H,4H)-diones, as inhibitors of HIV-1 integrase and/or the HIV-1 reverse transcriptase ribonuclease H domain: discovery of a novel selective inhibitor of the ribonuclease H function.
    Billamboz M; Bailly F; Lion C; Touati N; Vezin H; Calmels C; Andréola ML; Christ F; Debyser Z; Cotelle P
    J Med Chem; 2011 Mar; 54(6):1812-24. PubMed ID: 21366258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: influence of the alkylation of position 4.
    Billamboz M; Bailly F; Lion C; Calmels C; Andréola ML; Witvrouw M; Christ F; Debyser Z; De Luca L; Chimirri A; Cotelle P
    Eur J Med Chem; 2011 Feb; 46(2):535-46. PubMed ID: 21185110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.
    Billamboz M; Bailly F; Barreca ML; De Luca L; Mouscadet JF; Calmels C; Andréola ML; Witvrouw M; Christ F; Debyser Z; Cotelle P
    J Med Chem; 2008 Dec; 51(24):7717-30. PubMed ID: 19053754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs), novel inhibitors of HIV integrase with a high barrier to resistance.
    Desimmie BA; Demeulemeester J; Suchaud V; Taltynov O; Billamboz M; Lion C; Bailly F; Strelkov SV; Debyser Z; Cotelle P; Christ F
    ACS Chem Biol; 2013; 8(6):1187-94. PubMed ID: 23517458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of a novel series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as human immunodeficiency virus type 1 integrase inhibitors.
    Suchaud V; Bailly F; Lion C; Calmels C; Andréola ML; Christ F; Debyser Z; Cotelle P
    J Med Chem; 2014 Jun; 57(11):4640-60. PubMed ID: 24793360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a series of 3-hydroxyquinolin-2(1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity.
    Suchaud V; Bailly F; Lion C; Tramontano E; Esposito F; Corona A; Christ F; Debyser Z; Cotelle P
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3988-92. PubMed ID: 22607675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs) as human immunodeficiency virus type 1 integrase inhibitors: Influence of the alkylcarboxamide substitution of position 4.
    Billamboz M; Suchaud V; Bailly F; Lion C; Andréola ML; Christ F; Debyser Z; Cotelle P
    Eur J Med Chem; 2016 Jul; 117():256-68. PubMed ID: 27105029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity.
    Esposito F; Ambrosio FA; Maleddu R; Costa G; Rocca R; Maccioni E; Catalano R; Romeo I; Eleftheriou P; Karia DC; Tsirides P; Godvani N; Pandya H; Corona A; Alcaro S; Artese A; Geronikaki A; Tramontano E
    Eur J Med Chem; 2019 Nov; 182():111617. PubMed ID: 31442684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral activity of metal-chelating HIV-1 integrase inhibitors.
    Carcelli M; Rogolino D; Sechi M; Rispoli G; Fisicaro E; Compari C; Grandi N; Corona A; Tramontano E; Pannecouque C; Naesens L
    Eur J Med Chem; 2014 Aug; 83():594-600. PubMed ID: 24996145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors.
    Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8420-9. PubMed ID: 17005407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity.
    Cai CW; Lomonosova E; Moran EA; Cheng X; Patel KB; Bailly F; Cotelle P; Meyers MJ; Tavis JE
    Antiviral Res; 2014 Aug; 108():48-55. PubMed ID: 24858512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase.
    Tang J; Vernekar SKV; Chen YL; Miller L; Huber AD; Myshakina N; Sarafianos SG; Parniak MA; Wang Z
    Eur J Med Chem; 2017 Jun; 133():85-96. PubMed ID: 28384548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.
    Robinson WE; Cordeiro M; Abdel-Malek S; Jia Q; Chow SA; Reinecke MG; Mitchell WM
    Mol Pharmacol; 1996 Oct; 50(4):846-55. PubMed ID: 8863829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivatives of 5-nitro-furan-2-carboxylic acid carbamoylmethyl ester inhibit RNase H activity associated with HIV-1 reverse transcriptase.
    Fuji H; Urano E; Futahashi Y; Hamatake M; Tatsumi J; Hoshino T; Morikawa Y; Yamamoto N; Komano J
    J Med Chem; 2009 Mar; 52(5):1380-7. PubMed ID: 19178289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro.
    Tramontano E; Esposito F; Badas R; Di Santo R; Costi R; La Colla P
    Antiviral Res; 2005 Feb; 65(2):117-24. PubMed ID: 15708638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors.
    Esposito F; Sechi M; Pala N; Sanna A; Koneru PC; Kvaratskhelia M; Naesens L; Corona A; Grandi N; di Santo R; D'Amore VM; Di Leva FS; Novellino E; Cosconati S; Tramontano E
    Antiviral Res; 2020 Feb; 174():104671. PubMed ID: 31812637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones.
    Didierjean J; Isel C; Querré F; Mouscadet JF; Aubertin AM; Valnot JY; Piettre SR; Marquet R
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4884-94. PubMed ID: 16304149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.
    Plewe MB; Butler SL; Dress KR; Hu Q; Johnson TW; Kuehler JE; Kuki A; Lam H; Liu W; Nowlin D; Peng Q; Rahavendran SV; Tanis SP; Tran KT; Wang H; Yang A; Zhang J
    J Med Chem; 2009 Nov; 52(22):7211-9. PubMed ID: 19873974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity.
    Wang L; Tang J; Huber AD; Casey MC; Kirby KA; Wilson DJ; Kankanala J; Xie J; Parniak MA; Sarafianos SG; Wang Z
    Eur J Med Chem; 2018 Aug; 156():652-665. PubMed ID: 30031976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal-dependent inhibition of HIV-1 integrase.
    Neamati N; Lin Z; Karki RG; Orr A; Cowansage K; Strumberg D; Pais GC; Voigt JH; Nicklaus MC; Winslow HE; Zhao H; Turpin JA; Yi J; Skalka AM; Burke TR; Pommier Y
    J Med Chem; 2002 Dec; 45(26):5661-70. PubMed ID: 12477350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.